Stock market today: Dow drops, S&P 500 and Nasdaq slip from records as Wall Street counts down to Fed decision

US equities experienced a minor pullback from record highs on Tuesday as investors focused on the Federal Reserve's policy meeting, where a 25 basis point rate cut is widely anticipated, despite August retail sales exceeding expectations with a 0.6% rise, indicating resilient consumer spending. Geopolitical tensions drove oil prices higher following Ukrainian attacks on Russian energy infrastructure, while gold reached new records. Notable corporate movements included Oracle gaining on reports of its involvement in a US-China TikTok deal, Hims & Hers falling due to an FDA warning letter, and Warner Bros. Discovery declining after analyst downgrades following speculative acquisition rumors.

Analysis

U.S. equity markets pulled back from record highs as investor focus shifted to the Federal Reserve's policy meeting, where a 25-basis-point interest rate cut is widely anticipated with 96% probability. This expectation persists despite stronger-than-expected economic data, notably a 0.6% month-over-month increase in August retail sales against a 0.2% forecast, indicating resilient consumer spending. Geopolitical factors influenced commodity markets, with WTI and Brent crude oil rising over 1% on supply concerns following Ukrainian attacks on Russian energy infrastructure. In corporate news, Hims & Hers (HIMS) shares fell 7% after the FDA issued a warning letter for 'false or misleading claims,' compounding reputational issues and highlighting the risk associated with its high short interest of approximately 30%. Conversely, Warner Bros. Discovery (WBD) sank 8% as analysts at TD Cowen and Morningstar downgraded the stock to 'Hold', citing the speculative nature of its recent 50% rally which was based on an unsubstantiated acquisition report. Positive catalysts lifted Oracle (ORCL) by nearly 3% on reports of its key role in a forthcoming US-China TikTok deal, and Novo Nordisk (NVO) gained over 2% on plans to seek FDA approval for a new high-dose obesity drug. Meanwhile, Ralph Lauren (RL) shares dipped over 1% after providing a disappointing three-year outlook targeting mid-single-digit revenue growth, a deceleration from its recent 6.8% expansion.

Key Decisions for Investors

• Given the disconnect between strong retail sales data and the market's expectation of a 25bp Fed rate cut, investors should be prepared for potential market volatility following the Fed's announcement, as any hawkish tone could challenge the current rally.
• The 8% drop in Warner Bros. Discovery (WBD) on analyst downgrades suggests its recent rally was speculative; positions should be re-evaluated for risk, as the stock could revert to the $11-$12 range if acquisition rumors do not materialize.
• The FDA warning and high short interest in Hims & Hers (HIMS) signal significant regulatory and downside risk, warranting extreme caution for long positions and making it a potential candidate for short-side monitoring.
• Oracle's (ORCL) reported involvement in the TikTok deal and Novo Nordisk's (NVO) pipeline progress represent distinct, positive fundamental catalysts that could support continued outperformance against the broader market.
• Ralph Lauren's (RL) guidance for decelerating revenue growth to the mid-single digits over the next three years suggests a need to temper long-term growth expectations and scrutinize the impact of macroeconomic pressures on the brand.